Zymar - Gatifloxacin ophthalmic solution, 0.3% - Allergan - Fluoroquinolone approved for bacterial conjunctivitis

被引：0

|

作者：

不详

机构：

来源：

FORMULARY | 2003年 / 38卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：353 / 353

页数：1

相关论文

共 47 条

[31] Effect of gatifloxacin ophthalmic solution 0.3% on corneal endothelial cell counts in normal subjects and in cataract surgery patients
Price, MO
Price, FW
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U546 - U546
[32] A PLACEBO CONTROLLED TRIAL OF NORFLOXACIN OPHTHALMIC SOLUTION (NFX) IN ACUTE BACTERIAL CONJUNCTIVITIS (ABC)
VOGEL, R
LAIBOVITZ, R
CASTAN, R
MILLER, I
WITTREICH, J
COOK, TJ
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 937 - 937
[33] Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients
Lichtenstein, SJ
Rinehart, M
JOURNAL OF AAPOS, 2003, 7 (05): : 317 - 324
[34] Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX®) in pediatric and nonpediatric patients with bacterial conjunctivitis
Silver, LH
Woodside, AM
Montgomery, DB
SURVEY OF OPHTHALMOLOGY, 2005, 50 : S55 - S63
[35] Pediatric efficacy and safety of 0.5% levofloxacin ophthalmic solution (LVFX) for the treatment of bacterial conjunctivitis.
Graves, AL
Lichtenstein, SJ
Moran, CT
Dell, SJ
Van Buskirk, AL
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S148 - S148
[36] SUCCESSFUL TREATMENT OF BACTERIAL CORNEAL ULCERATION WITH 0.3-PERCENT-OFLOXACIN OPHTHALMIC SOLUTION
SRINIVASAN, M
STOECKER, JF
SUNDAR, K
JENSEN, HG
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S154 - S154
[37] A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis
Hwang, DG
Schanzlin, DJ
Rotberg, MH
Foulks, G
Raizman, MB
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (08) : 1004 - 1009
[38] RESULTS OF A SURVEY OF CHILDREN WITH ACUTE BACTERIAL CONJUNCTIVITIS TREATED WITH TRIMETHOPRIM-POLYMYXIN-B OPHTHALMIC SOLUTION
WAGNER, RS
CLINICAL THERAPEUTICS, 1995, 17 (05) : 875 - 881
[39] A randomized, investigator-masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment of acute bacterial conjunctivitis
Yee, RW
Tepedino, M
Bernstein, P
Jensen, H
Schiffman, R
Whitcup, SM
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (03) : 425 - 431
[40] Moxifloxacin Ophthalmic Solution 0.5% hastens cure and eradicates the causative pathogens of bacterial conjunctivitis in pediatric and adult patients
Katz, HR
Andrews, W
Creager, D
De Leon, J
Merkley, K
Gower, L
Stroman, DW
Nicholson, N
Potts, S
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U355 - U355

← 1 2 3 4 5 →